# Avalyn Pharma Inc. Common Stock (AVLN)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/AVLN/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -55.80M | $ -56.55M | $ 17.11M | $ 398.35M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.04 |
| Liabilities / Eq | 0.07 |
| Current Ratio | 33.10 |

## Other views

- [Metrics](https://sponda.capital/en/AVLN.md)
- [Charts](https://sponda.capital/en/AVLN/charts.md)
- [Compare](https://sponda.capital/en/AVLN/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.